Controlled release formulations

Details for Australian Patent Application No. 2005212355 (hide)

Owner Innovative Drug Delivery Systems, Inc.

Inventors Mermelstein, Fred; Moshman, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005212355

PCT Pub. Number WO2005/077346

Priority 10/776,333 10.02.04 US

Filing date 9 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 17 June 2010

International Classifications

A61K 31/00 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/077346 Priority application(s): WO2005/077346

17 June 2010 Application Accepted

  Published as AU-B-2005212355

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212356-Fastening member for a molded article

2005212352-Systems and methods for spinal surgery